-
公开(公告)号:US10561741B2
公开(公告)日:2020-02-18
申请号:US15553855
申请日:2016-03-03
Applicant: UNIVERSITY OF MIAMI
Inventor: Paolo Serafini , Jennifer Vella , Vincenzo Bronte , Pirouz Daftarian , Angel Kaifer , Serena Zilio
IPC: A61K47/69 , A61K47/59 , A61K47/64 , A61P35/00 , A61K31/683 , A61K31/713 , A61K49/00 , C12N15/113
Abstract: Described herein are nanoparticle-based compositions, kits and methods and platforms for delivering one or more nucleic acids to a myeloid cell.
-
公开(公告)号:US20150139904A1
公开(公告)日:2015-05-21
申请号:US14403107
申请日:2013-05-21
Applicant: University of Miami
Inventor: Omaida Velazquez , Sylvia Daunert , Pirouz Daftarian , Liu Zhao-Jun , Sapna Deo
CPC classification number: A61K47/58 , A61K35/28 , A61K38/00 , A61K47/54 , A61K47/6425 , A61K49/0004 , C07K14/705 , C07K14/70503 , C07K14/70596
Abstract: The present invention provides dendrimer conjugates. The present invention provides a composition comprising a dendrimer conjugate and a cell, such as a cell covered with dendrimer conjugates, in which dendrimer conjugates home the cell to a target tissue.
Abstract translation: 本发明提供树枝状聚合物共轭物。 本发明提供包含树枝状聚合物缀合物和细胞的组合物,例如覆盖有树枝状聚合物缀合物的细胞,其中树枝状大分子将细胞接合到靶组织。
-
公开(公告)号:US11364305B2
公开(公告)日:2022-06-21
申请号:US16792667
申请日:2020-02-17
Applicant: UNIVERSITY OF MIAMI
Inventor: Paolo Serafini , Jennifer Vella , Vincenzo Bronte , Pirouz Daftarian , Angel Kaifer , Serena Zilio
IPC: A61K47/69 , C12N15/113 , A61K31/7105 , C07K7/06 , A61K47/60 , A61K38/00
Abstract: Described herein are nanoparticle-based compositions, kits and methods and platforms for delivering one or more nucleic acids to a cell.
-
公开(公告)号:US20220023421A1
公开(公告)日:2022-01-27
申请号:US17404538
申请日:2021-08-17
Applicant: University of Miami
Inventor: Victor L. Perez Quinones , Pirouz Daftarian
IPC: A61K39/395 , C07K14/47 , C12N5/16 , A61K47/64 , A61K47/59 , A61K39/39 , A61K47/50 , A61P37/00 , A61P31/00 , A61P29/00 , A61P35/00 , A61K9/51
Abstract: Conjugates of synthetic nanocarriers, complexed with syngeneic (self) proteins adducted with haptens or other poorly immunogenic antigens (antigens of low immunogenicity), elicit selective humoral responses or antibodies against the hapten or antigen and not to self-protein. Compositions include these conjugates, which can be used as vaccines. Methods of making and using them are described herein. In a typical embodiment, a conjugate including a hapten or antigen of low immunogenicity associated with a particular disease (e.g., infection, cancer) can be used as a vaccine by eliciting antibodies that specifically neutralize the hapten or antigen. These hapten (and other poorly immunogenic antigen)-carrying nanocarriers selectively target antigen presenting cells resulting in a strong anti-hapten humoral response, and thus find use in vaccines for cancer (e.g., cancers of lung, cervix, breast, brain, liver pancreas, ovaries, skin, etc.), infectious diseases and inflammatory-mediated diseases, as well as for autoimmune disorders.
-
公开(公告)号:US20200237928A1
公开(公告)日:2020-07-30
申请号:US16792667
申请日:2020-02-17
Applicant: UNIVERSITY OF MIAMI
Inventor: Paolo Serafini , Jennifer Vella , Vincenzo Bronte , Pirouz Daftarian , Angel Kaifer , Serena Zilio
IPC: A61K47/69 , C12N15/113 , A61K31/7105 , A61K47/60 , C07K7/06
Abstract: Described herein are nanoparticle-based compositions, kits and methods and platforms for delivering one or more nucleic acids to a cell.
-
公开(公告)号:US20190184013A1
公开(公告)日:2019-06-20
申请号:US16302457
申请日:2017-05-23
Applicant: University of Miami
Inventor: Victor L. Perez Quinones , Pirouz Daftarian
CPC classification number: A61K39/39558 , A61K9/51 , A61K39/39 , A61K47/50 , A61K47/595 , A61K47/643 , A61K47/646 , A61K2039/55555 , A61K2039/55566 , A61K2039/6031 , A61K2039/645 , A61P29/00 , A61P31/00 , A61P35/00 , A61P37/00 , C07K14/47 , C12N5/163
Abstract: Conjugates of synthetic nanocarriers, complexed with syngeneic (self) proteins adducted with haptens or other poorly immunogenic antigens (antigens of low immunogenicity), elicit selective humoral responses or antibodies against the hapten or antigen and not to self-protein. Compositions include these conjugates, which can be used as vaccines. Methods of making and using them are described herein. In a typical embodiment, a conjugate including a hapten or antigen of low immunogenicity associated with a particular disease (e.g., infection, cancer) can be used as a vaccine by eliciting antibodies that specifically neutralize the hapten or antigen. These hapten (and other poorly immunogenic antigen)-carrying nanocarriers selectively target antigen presenting cells resulting in a strong anti-hapten humoral response, and thus find use in vaccines for cancer (e.g., cancers of lung, cervix, breast, brain, liver pancreas, ovaries, skin, etc.), infectious diseases and inflammatory-mediated diseases, as well as for autoimmune disorders.
-
公开(公告)号:US20180050111A1
公开(公告)日:2018-02-22
申请号:US15639473
申请日:2017-06-30
Applicant: UNIVERSITY OF MIAMI
Inventor: Omaida Velazquez , Sylvia Daunert , Pirouz Daftarian , Zhao-Jun Liu , Sapna Deo
IPC: C07K14/705 , A61K49/00 , A61K35/28 , A61K38/00
CPC classification number: A61K47/58 , A61K35/28 , A61K38/00 , A61K47/54 , A61K47/6425 , A61K49/0004 , C07K14/705 , C07K14/70503 , C07K14/70596
Abstract: The present invention provides dendrimer conjugates. The present invention provides a composition comprising a dendrimer conjugate and a cell, such as a cell covered with dendrimer conjugates, in which dendrimer conjugates home the cell to a target tissue.
-
公开(公告)号:US11253602B2
公开(公告)日:2022-02-22
申请号:US16567731
申请日:2019-09-11
Applicant: University of Miami
Inventor: Omaida Velazquez , Sylvia Daunert , Pirouz Daftarian , Zhao-Jun Liu , Sapna Deo
Abstract: The present invention provides dendrimer conjugates. The present invention provides a composition comprising a dendrimer conjugate and a cell, such as a cell covered with dendrimer conjugates, in which dendrimer conjugates home the cell to a target tissue.
-
公开(公告)号:US20180243443A1
公开(公告)日:2018-08-30
申请号:US15553855
申请日:2016-03-03
Applicant: UNIVERSITY OF MIAMI
Inventor: Paolo Serafini , Jennifer Vella , Vicenzo Bronte , Pirouz Daftarian , Angel Kaifer , Serena Zilio
IPC: A61K47/69 , C12N15/113 , A61K47/59 , A61K49/00 , A61K47/64 , A61K31/683 , A61K31/713 , A61P35/00
CPC classification number: A61K47/6935 , A61K31/683 , A61K31/713 , A61K47/595 , A61K47/642 , A61K49/0004 , A61P35/00 , C12N15/1135 , C12N2310/122 , C12N2310/141 , C12N2310/3513 , C12N2310/531
Abstract: Described herein are nanoparticle-based compositions, kits and methods and platforms for delivering one or more nucleic acids to a myeloid cell.
-
公开(公告)号:US09737611B2
公开(公告)日:2017-08-22
申请号:US14403107
申请日:2013-05-21
Applicant: University of Miami
Inventor: Omaida Velazquez , Sylvia Daunert , Pirouz Daftarian , Zhao-Jun Liu , Sapna Deo
IPC: A61K47/48 , A61K49/00 , A61K35/28 , C07K14/705 , A61K38/00
CPC classification number: A61K47/58 , A61K35/28 , A61K38/00 , A61K47/54 , A61K47/6425 , A61K49/0004 , C07K14/705 , C07K14/70503 , C07K14/70596
Abstract: The present invention provides dendrimer conjugates. The present invention provides a composition comprising a dendrimer conjugate and a cell, such as a cell covered with dendrimer conjugates, in which dendrimer conjugates home the cell to a target tissue.
-
-
-
-
-
-
-
-
-